GB8510297D0 - 1 4-dihydro-4-oxonaphthyridine derivatives - Google Patents

1 4-dihydro-4-oxonaphthyridine derivatives

Info

Publication number
GB8510297D0
GB8510297D0 GB858510297A GB8510297A GB8510297D0 GB 8510297 D0 GB8510297 D0 GB 8510297D0 GB 858510297 A GB858510297 A GB 858510297A GB 8510297 A GB8510297 A GB 8510297A GB 8510297 D0 GB8510297 D0 GB 8510297D0
Authority
GB
United Kingdom
Prior art keywords
dihydro
oxonaphthyridine derivatives
oxonaphthyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB858510297A
Other versions
GB2158825B (en
GB2158825A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB8510297(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of GB8510297D0 publication Critical patent/GB8510297D0/en
Publication of GB2158825A publication Critical patent/GB2158825A/en
Application granted granted Critical
Publication of GB2158825B publication Critical patent/GB2158825B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GB08510297A 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof Expired GB2158825B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (en) 1984-04-26 1984-04-26 1,4-dihydro-4-oxonaphthyridine derivative and salt thereof

Publications (3)

Publication Number Publication Date
GB8510297D0 true GB8510297D0 (en) 1985-05-30
GB2158825A GB2158825A (en) 1985-11-20
GB2158825B GB2158825B (en) 1989-01-25

Family

ID=13845280

Family Applications (2)

Application Number Title Priority Date Filing Date
GB08510297A Expired GB2158825B (en) 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof
GB8716897A Expired - Lifetime GB2191776B (en) 1984-04-26 1987-07-17 1, 4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8716897A Expired - Lifetime GB2191776B (en) 1984-04-26 1987-07-17 1, 4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same

Country Status (30)

Country Link
JP (1) JPS60228479A (en)
KR (1) KR870001693B1 (en)
AR (1) AR241911A1 (en)
AT (2) AT389698B (en)
AU (2) AU565087B2 (en)
BE (1) BE902279A (en)
CH (1) CH673458A5 (en)
CS (1) CS250684B2 (en)
DD (1) DD238795A5 (en)
DE (2) DE3546658C2 (en)
DK (1) DK165877C (en)
EG (1) EG17339A (en)
ES (2) ES8700256A1 (en)
FI (1) FI80453C (en)
FR (2) FR2563521B1 (en)
GB (2) GB2158825B (en)
HU (2) HU194226B (en)
ID (1) ID21142A (en)
IL (1) IL75021A (en)
IT (1) IT1209953B (en)
LU (1) LU85871A1 (en)
NL (2) NL187314C (en)
NO (1) NO162238C (en)
NZ (1) NZ211895A (en)
PH (3) PH22801A (en)
PL (1) PL147392B1 (en)
PT (1) PT80349B (en)
RO (2) RO95509B (en)
SE (2) SE463102B (en)
ZA (1) ZA853102B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114369092A (en) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 Tosufloxacin tosylate and preparation method thereof

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (en) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd Pyridyl ketone derivative
AT392789B (en) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd METHOD FOR PRODUCING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (en) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen ANTIBACTERIAL EFFECT OF CHINOLON CARBON ACID ESTERS
ATE75740T1 (en) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co PYRIDONECARBONIC ACID DERIVATIVES.
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (en) * 1988-05-23 1999-01-06 塩野義製薬株式会社 Pyridonecarboxylic acid antibacterial agent
DE3934082A1 (en) * 1989-10-12 1991-04-18 Bayer Ag CHINOLON CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ANTIVIRAL AGENT
AU1161492A (en) * 1991-01-14 1992-08-17 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (en) * 1992-05-26 1996-02-02 Bouchara Sa NOVEL FLUORINATED QUINOLONES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
KR940014395A (en) * 1992-12-09 1994-07-18 강박광 Novel quinolone derivatives and preparation methods thereof
KR0148277B1 (en) * 1993-01-18 1998-11-02 채영복 Novel fluoroquinolone derivatives and process for the preparation thereof
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (en) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 Novel quinolone derivatives and methods for their preparation
US5910498A (en) * 1994-10-20 1999-06-08 Wakunaga Seiyaku Kabushiki Kaisha Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
WO1997040036A1 (en) 1996-04-19 1997-10-30 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient
IL129597A0 (en) * 1996-10-30 2000-02-29 Bayer Ag Process for the preparation of naphthyridine compounds and novel intermediates
DE19713506A1 (en) 1997-04-01 1998-10-08 Bayer Ag Process for the preparation of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyrid-6-one monosodium salt and its tautomers
CN1343128B (en) 1999-03-17 2010-04-21 第一制药株式会社 Medicinal compositions
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
US6586420B1 (en) 1999-09-02 2003-07-01 Wakunaga Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative or its salt
WO2002018345A1 (en) * 2000-08-29 2002-03-07 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (en) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 Process for preparing 7-chloro-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
CN101792443A (en) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 Fluoro-carbostyril derivative as well as preparation method and application thereof
JOP20190045A1 (en) 2016-09-14 2019-03-14 Bayer Ag 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (en) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co A PROCEDURE FOR PREPARING 6-HALOGEN-4-OXO-7- (1-PIPERAZINYL) -1,8-NAFTIRIDIN-3-CARBOXYLIC ACID DERIVATIVES
DE3033157A1 (en) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-NAPHTHYRIDINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (en) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen ANTIBACTERIAL EFFECT OF CHINOLON CARBON ACID ESTERS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114369092A (en) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 Tosufloxacin tosylate and preparation method thereof

Also Published As

Publication number Publication date
DK185685D0 (en) 1985-04-25
HU194226B (en) 1988-01-28
PH25046A (en) 1991-01-28
GB2191776A (en) 1987-12-23
IL75021A0 (en) 1985-08-30
IL75021A (en) 1994-01-25
GB2191776B (en) 1990-03-28
GB8716897D0 (en) 1987-08-26
SE8502017D0 (en) 1985-04-25
IT8548002A0 (en) 1985-04-26
RO91871A (en) 1987-07-30
IT1209953B (en) 1989-08-30
FR2563521B1 (en) 1989-02-03
NZ211895A (en) 1988-07-28
NL8501172A (en) 1985-11-18
LU85871A1 (en) 1985-12-16
NO162238C (en) 1989-12-06
ES8706673A1 (en) 1987-07-01
ATA267888A (en) 1989-09-15
RO95509B (en) 1988-10-01
SE501412C2 (en) 1995-02-13
AU8180487A (en) 1988-03-24
FI851637L (en) 1985-10-27
PT80349B (en) 1987-09-30
FR2614620A1 (en) 1988-11-04
ES542584A0 (en) 1986-09-16
ZA853102B (en) 1986-12-30
PL147392B1 (en) 1989-05-31
JPS6320828B2 (en) 1988-04-30
EG17339A (en) 1989-06-30
DE3546658C2 (en) 1992-04-02
AU565087B2 (en) 1987-09-03
BE902279A (en) 1985-10-25
FR2563521A1 (en) 1985-10-31
DK185685A (en) 1985-10-27
HU197571B (en) 1989-04-28
PH22801A (en) 1988-12-12
ID21142A (en) 1999-04-29
SE463102B (en) 1990-10-08
KR870001693B1 (en) 1987-09-24
CH673458A5 (en) 1990-03-15
AU4165085A (en) 1985-10-31
PL253108A1 (en) 1985-12-17
NL187314C (en) 1991-08-16
RO91871B (en) 1987-07-31
GB2158825B (en) 1989-01-25
ATA122485A (en) 1989-06-15
AT389698B (en) 1990-01-10
FR2614620B1 (en) 1990-03-09
AU612993B2 (en) 1991-07-25
PH25228A (en) 1991-03-27
FI80453C (en) 1990-06-11
KR850007596A (en) 1985-12-07
HUT38634A (en) 1986-06-30
SE8804586L (en) 1988-12-20
AR241911A1 (en) 1993-01-29
DK165877C (en) 1993-06-21
FI80453B (en) 1990-02-28
NO851643L (en) 1985-10-28
SE8804586D0 (en) 1988-12-20
NL9100648A (en) 1991-08-01
NO162238B (en) 1989-08-21
ES551538A0 (en) 1987-07-01
RO95509A (en) 1988-09-30
JPS60228479A (en) 1985-11-13
FI851637A0 (en) 1985-04-25
DK165877B (en) 1993-02-01
SE8502017L (en) 1985-10-27
CS250684B2 (en) 1987-05-14
AT390258B (en) 1990-04-10
DE3514076C2 (en) 1989-03-30
DD238795A5 (en) 1986-09-03
ES8700256A1 (en) 1986-09-16
GB2158825A (en) 1985-11-20
DE3514076A1 (en) 1985-10-31
PT80349A (en) 1985-05-01

Similar Documents

Publication Publication Date Title
GB2163150B (en) 3-aminopropoxyaryl derivatives
GB2152033B (en) Sulfonamido-benzamide derivatives
EP0163324A3 (en) Aminoalkylphenoxy derivatives
GB8510297D0 (en) 1 4-dihydro-4-oxonaphthyridine derivatives
GB2155925B (en) Pyrimidylpiperazine derivatives
GB2164644B (en) Benzonorbornene derivatives
DE3565267D1 (en) 9a-aza-9a-homoerythromycin derivatives
GB2159814B (en) Iminothiazolidine derivatives
GB2165845B (en) Dioxinopyridine derivatives
GB2162178B (en) 4-cyano-3-oxo-hexahydro-isoquinoline derivatives
GB2165247B (en) Azabicycloheptene derivatives
EP0174271A3 (en) Anthraceme derivatives
GB2158066B (en) Apovincaminol derivatives
PH22634A (en) 3 substituted thiopyrones
GB8507490D0 (en) Preparing 2 2-bishalomethylpenam derivatives
GB2154238B (en) 2 imidomethyl-penem derivatives
CS733884A1 (en) Zpusob izolace 8 chinolinolu
CS782984A1 (en) Zpusob deleni slozek 3 pikolinove frakce
GB8407793D0 (en) 13 14 19 20-retrade-hydro derivatives
GB8430451D0 (en) 2 6-dioxopiperidine derivatives
GB8407794D0 (en) 13 14 19 19 20 20-hexadehydro derivatives
GB8432463D0 (en) 10beta-alkynyl-4 9(11)-estradiene derivatives
GB2165243B (en) 17-sulphonamido yohimbane derivatives
CS328984A1 (en) Zpusob stanoveni 5 sulfoisoftalove kyseliny v elektrolytickych vybarvovacich roztocich
CS61384A2 (en) Zpusob vyroby derivatu pyridazinu substituovanych v poloze 3 substituovanou aminoskupinou

Legal Events

Date Code Title Description
727 Application made for amendment of specification (sect. 27/1977)
727A Application for amendment of specification now open to opposition (sect. 27/1977)
727B Case decided by the comptroller ** specification amended (sect. 27/1977)
SP Amendment (slips) printed
PE20 Patent expired after termination of 20 years

Effective date: 20050422